InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-42.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Ely James S. III, Director. Insider active across 2 companies, notably Select Medical Holdings CORP. Cumulatively, 19 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €48k. History available since 4 May 2021. The latest transaction was filed on 1 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ely James S. III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
9,756 股0Common StockSEC:0001193125-26-088411:0
2,882 股0Common StockSEC:0001193125-25-338341:0
14,035 股0Common StockSEC:0001415889-25-020758:0
5,894 股0Common StockSEC:0000950170-25-031092:0
10,000 股0Common StockSEC:0001415889-24-011920:0
5,894 股0Common StockSEC:0000950170-24-024212:0
798 股@ US$22.569.7% 占其流量Common StockSEC:0001415889-23-014738:0
602 股@ US$29.929.3% 占其流量Common StockSEC:0001415889-23-011753:0
615 股@ US$29.299.3% 占其流量Common StockSEC:0001415889-23-007237:0
602 股@ US$29.909.6% 占其流量Common StockSEC:0001415889-23-002706:0
689 股@ US$26.1310.4% 占其流量Common StockSEC:0001415889-22-011071:0
10,000 股0Common StockSEC:0001415889-22-008228:0
10,000 股@ US$5.120.012% mcap100.0% 占其流量Common StockSEC:0001209191-22-033525:0
标准退出：2022年8月29日 (T+90)
778 股@ US$23.150.0007% mcap16.5% 占其流量Common StockSEC:0001179110-22-002859:0
11,356 股0Common StockSEC:0001209191-22-014970:0
745 股@ US$24.170.0007% mcap16.3% 占其流量Common StockSEC:0001179110-22-001446:0
531 股@ US$33.890.0008% mcap17.1% 占其流量Common StockSEC:0001179110-21-009835:0
6,000 股0Common StockSEC:0001179110-21-007942:0
471 股@ US$38.2210.3% 占其流量Common StockSEC:0001179110-21-004934:0
19 条申报中的 19 条
About Ely James S. III
Ely James S. III is a Director of Select Medical Holdings CORP and Community Health Systems INC. The declarant has 19 filings in total, and among the sampled recent filings, the period runs from 2021-05-05 to 2026-03-03, with EUR 47698 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution.
